Non-small cell lung cancer (NSCLC) Clinical Trials in Salt Lake City, UT
As of September 2026, 27 paid clinical trials are recruiting for Non-small cell lung cancer (NSCLC) in Salt Lake City, Utah. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Salt Lake City
Filter results
27 clinical trials for Non-small cell lung cancer (NSCLC)
·Clear filters·A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
Top Research Study Locations in Salt Lake City
Researchers run research studies in Salt Lake City, UT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Utah | Stroke, Traumatic Brain Injury, Acute Myeloid Leukemia | 211 |
| Huntsman Cancer Institute/University of Utah | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 70 |
| Primary Children's Hospital | Neuroblastoma, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia | 62 |
| Huntsman Cancer Institute | Multiple Myeloma, Colorectal Cancer, NSCLC | 58 |
| Huntsman Cancer Institute, University of Utah | Advanced Solid Tumor, Breast Cancer, HIV Infection | 34 |
| University of Utah Health | Heart Failure, Interstitial Lung Disease, Hemorrhagic Stroke | 30 |
| University of Utah Hospital | Cardiovascular Diseases, Abdominal Aortic Aneurysm, Cirrhosis | 23 |
| Huntsman Cancer Institute at University of Utah | Gynecologic Cancer, Breast Cancer, Metastatic Castration-resistant Prostate Cancer | 23 |
| VA Salt Lake City Health Care System, Salt Lake City, UT | Aging, Alcohol Use Disorder, Alcohol Use Disorder (AUD) | 19 |
| University of Utah Sugarhouse Health Center | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 16 |
| Utah Cancer Specialists | Colorectal Cancer, Multiple Myeloma, NSCLC | 14 |
| Huntsman Cancer Institute at the University of Utah | Multiple Myeloma, Non-Hodgkin Lymphoma, Plasma Cell Leukemia | 14 |
| LDS Hospital | Carbon Monoxide Poisoning, Cardiovascular Diseases, Castration-Sensitive Prostate Carcinoma | 11 |
| The University of Utah | Bowel; Stricture, Cardiovascular Disease and Lipoprotein(a), Cerebral Palsy | 11 |
| University of Utah Huntsman Cancer Institute | Advanced Melanoma, Breast Cancer, ARID1A Gene Mutation | 11 |
| Intermountain Healthcare | Large B-cell Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma | 10 |
| University of Utah Orthopaedic Center | Acetabular Fracture, Chronic Low-back Pain, Chronic Pain | 8 |
| Clinical Trial Site | Acute Hepatic Porphyria, Breast Cancer, ER Positive Breast Cancer | 7 |
| University of Utah - Huntsman Cancer Institute | Advanced Solid Tumor, Bladder Cancer, Breast Cancer | 7 |
| University of Utah Orthopedics | Ankle Injuries, Cervical Myelopathy, Early Mobilization | 7 |
| GSK Investigational Site | HIV Infections, Gastrointestinal Neoplasms, Hypereosinophilic Syndrome | 6 |
| Intermountain Health | Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Ovarian Carcinoma | 6 |
| St. Mark's Hospital | Persistent Atrial Fibrillation, AV Block, Atrial Fibrillation | 6 |
| The Eye Institute of Utah | Anterior Segment of Eye, Aphakia, Astigmatism | 6 |
| University of Utah Healthcare | Intracerebral Hemorrhage, Atrial Fibrillation, Basal Ganglia Intracerebral Hemorrhage | 6 |
Active & Upcoming Studies in Salt Lake City (2026)
Recruiting trials in Salt Lake City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (303 active studies)
- Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial · Phase 2 · National Cancer Institute (NCI)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
Neurology & pain (75 active studies)
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease · Phase 4 · VA Office of Research and Development
- A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Cardiovascular (66 active studies)
- Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial · Phase 3 · The George Washington University Biostatistics Center
- INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery · Abiomed Inc.
Diabetes & metabolic (33 active studies)
- Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema · Phase 3 · Novo Nordisk A/S
- Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah) · University of Utah
Eye & vision (19 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA). · University of Utah
Pediatric (19 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study · Carelon Research
Mental health & behavior (16 active studies)
- KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury · Phase 2 · Irma Fleming
- LLM Intervention for Tobacco in Underserved Populations (LIFT-UP) · University of Utah
Vaccines (9 active studies)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
- Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above. · Phase 1, Phase 2 · Sanofi
HIV / STI (6 active studies)
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
- A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 · Phase 2 · Gilead Sciences
Common conditions studied in Salt Lake City
- Breast Cancer (21 active studies)
- Acute Myeloid Leukemia (14 active studies)
- Multiple Myeloma (13 active studies)
- Advanced Solid Tumor (12 active studies)
- Heart Failure (11 active studies)
- Ovarian Cancer (10 active studies)
Leading research sponsors in Salt Lake City
- University of Utah
- National Cancer Institute (NCI)
- VA Office of Research and Development
- Novartis Pharmaceuticals
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Salt Lake City?
There are approximately 959 recruiting clinical trials in Salt Lake City, Utah listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Salt Lake City pay participants?
Most recruiting trials in Salt Lake City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Salt Lake City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Salt Lake City?
The most common conditions under active study in Salt Lake City include Breast Cancer (21), Acute Myeloid Leukemia (14), Multiple Myeloma (13), Advanced Solid Tumor (12), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Salt Lake City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Salt Lake City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Salt Lake City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Salt Lake City?
Recruiting research sites in Salt Lake City include University of Utah, Huntsman Cancer Institute/University of Utah, Primary Children's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Salt Lake City right now?
The largest active categories in Salt Lake City are Cancer & tumors (303), Neurology & pain (75), Cardiovascular (66). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.